ask="16.45"
ask_size="500"
average_daily_volume="685625"
bid="16.10"
bid_size="200"
book_value="5.75"
change="+0.40"
change_from_200_day_moving_average="-1.91"
change_from_50_day_moving_average="-0.33"
change_from_52_week_high="-13.38"
change_From_52_week_low="4.01"
change_in_percent="+2.52%"
close="16.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.25"
ebitda="-70.16M"
eps_estimate_current_year="-2.39"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.79"
ex_dividend_date="N/A"
float_shares="23963000"
high="16.55"
high_52_weeks="29.63"
last_trade_date="1/5/2017"
last_trade_price="16.25"
last_trade_size="100"
last_trade_time="4:00pm"
low="15.80"
low_52_weeks="12.24"
market_capitalization="606.39M"
moving_average_200_day="18.16"
moving_average_50_day="16.58"
name="Global Blood Therapeutics
Inc."
notes="N/A"
one_year_target_price="50.83"
open="16.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-10.54%"
percent_change_from_50_day_moving_average="-1.98%"
percent_change_from_52_week_high="-45.16%"
percent_change_from_52_week_low="+32.76%"
previous_close="15.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.75"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37316000"
short_ratio="5.51"
stock_exchange="NMS"
symbol="GBT"
volume="600770"
weeks_range_52="12.24 - 29.63"
